@article{bf1567c4d4294360ab5803d06f13a243,
title = "Active Immunotherapy to Prevent Alzheimer Disease - A DNA Amyloid β 1-42 Trimer Vaccine",
author = "Rosenberg, {Roger N.} and Doris Lambracht-Washington",
note = "Funding Information: supported by National Institute on Aging/National Institutes of Health grants P30AG12300-21, RO3AG042697, and R03AG059201; the Zale Foundation, Rudman Partnership, McCune Foundation, AWARE, Presbyterian Village North Foundation, and Triumph Over Alzheimer{\textquoteright}s Disease Charity; the National Center for Advancing Translational Sciences of the National Institutes of Health under the Center for Translational Medicine's award UL1TR001105; a grant from the Friends of the Alzheimer{\textquoteright}s Disease Center; and Freiberger, Losinger, and Denker Family Funds. A US patent “Amyloid Beta Gene Vaccines” was granted in January 2009 to the University of Texas Southwestern Medical Center.",
year = "2020",
month = mar,
doi = "10.1001/jamaneurol.2019.4182",
language = "English (US)",
volume = "77",
pages = "289--290",
journal = "JAMA neurology",
issn = "2168-6149",
publisher = "American Medical Association",
number = "3",
}